Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease  T.A.O. Jiang,

Slides:



Advertisements
Similar presentations
Volume 65, Issue 1, Pages (January 2004)
Advertisements

Volume 78, Issue 9, Pages (November 2010)
Kidney Blood Press Res 2016;41: DOI: /
Volume 63, Issue 6, Pages (June 2003)
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
Figure 6 Cholesterol metabolism in obesity-related glomerulopathy
Volume 78, Issue 9, Pages (November 2010)
Volume 81, Issue 11, Pages (June 2012)
Volume 68, Issue 3, Pages (September 2005)
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
Renal manifestations in Fabry disease and therapeutic options
Bettina Haslinger-Löffler  Kidney International 
Volume 85, Issue 4, Pages (April 2014)
Volume 82, Issue 11, Pages (December 2012)
Volume 85, Issue 5, Pages (May 2014)
Volume 68, Issue 6, Pages (December 2005)
Volume 79, Issue 8, Pages (April 2011)
Volume 65, Issue 1, Pages (January 2004)
Volume 85, Issue 2, Pages (January 2014)
Glomerular disease related to anti-VEGF therapy
Volume 58, Issue 6, Pages (December 2000)
The kallikrein–kinin system in diabetic nephropathy
Volume 74, Issue 7, Pages (October 2008)
Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice
Volume 58, Issue 4, Pages (October 2000)
Volume 63, Issue 6, Pages (June 2003)
Volume 66, Issue 5, Pages (November 2004)
Volume 75, Issue 11, Pages (June 2009)
Volume 78, Issue 2, Pages (July 2010)
Expression of HIV transgene aggravates kidney injury in diabetic mice
Volume 77, Issue 11, Pages (June 2010)
Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy
Volume 79, Issue 1, Pages (January 2011)
C3 glomerulopathy: what's in a name?
Erik H. Strøm, Michael J. Mihatsch  Kidney International 
Proinflammatory effects of iron sucrose in chronic kidney disease
Volume 63, Issue 4, Pages (April 2003)
G.S. Markowitz, C. Gelber, V.D. D'agati  Kidney International 
Volume 70, Issue 3, Pages (August 2006)
Volume 60, Issue 6, Pages (December 2001)
Growth hormone promotes glomerular lipid accumulation in bGH mice
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 54, Issue 2, Pages (August 1998)
Volume 72, Issue 4, Pages (August 2007)
Volume 66, Issue 1, Pages (July 2004)
Volume 70, Issue 12, Pages (December 2006)
Glomerular injury is exacerbated in diabetic integrin α1-null mice
Volume 67, Issue 4, Pages (April 2005)
Volume 72, Issue 5, Pages (September 2007)
Prevention of mesangial sclerosis by bone marrow transplantation
Volume 72, Issue 12, Pages (December 2007)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Volume 66, Issue 5, Pages (November 2004)
AJKD Atlas of Renal Pathology: Minimal Change Disease
Volume 67, Issue 3, Pages (March 2005)
Fibrosis and renal aging
Mediterranean diets: are they practical in the Western world?
H. Raffi, J.M. Bates, Z. Laszik, S. Kumar  Kidney International 
Volume 64, Issue 6, Pages (December 2003)
Joel Z. Melnick, Patricia A. Preisig, Robert J. Alpern, Michel Baum 
Volume 80, Issue 10, Pages (November 2011)
Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti- neutrophil cytoplasmic antibodies  A. Chang, O. Aneziokoro, S.M.
Volume 56, Pages S28-S30 (July 1999)
Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis  Nosratola D. Vaziri, Tadashi Sato, Kaihui Liang 
The more or less ‘pristine’ renal allograft biopsy
Volume 75, Issue 5, Pages (March 2009)
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
Volume 74, Issue 8, Pages (October 2008)
Volume 56, Issue 6, Pages (December 1999)
Quiz page December 2003 American Journal of Kidney Diseases
Presentation transcript:

Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease  T.A.O. Jiang, Scott E. Liebman, M. Scott Lucia, Jinping Li, Moshe Levi  Kidney International  Volume 68, Issue 6, Pages 2608-2620 (December 2005) DOI: 10.1111/j.1523-1755.2005.00733.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Periodic acid-Schiff (PAS) staining of kidney cortex of 3-month-old (A), 6-month-old (B), 12-month-old (C), 19-month-old (D), and 23-month-old (E) mice. There was an age-associated increase in matrix accumulation, which was most evident after 12 months of age. Kidney International 2005 68, 2608-2620DOI: (10.1111/j.1523-1755.2005.00733.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Transmission electron microscopy of 3-month-old (A), 12-month-old (B), and 23-month-old (C) mice. There was an age-related increase in glomerular basement membrane thickness, as well as podocyte width. Increasing podocyte effacement was evident in the 12-month-old and 23-month-old mice. Kidney International 2005 68, 2608-2620DOI: (10.1111/j.1523-1755.2005.00733.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Basement membrane thickness (A) and podocyte width (B) of 3-month-old, 12-month-old, and 23-month-old mice. Both basement membrane thickness and podocyte width increased in an age-dependent manner (P < 0.0001 for trend of increase in both basement membrane thickening and podocyte width thickening). Comparisons of individual ages revealed significant differences between 3 months vs. 12 months and 23 months, and 12 months vs. 23 months for basement membrane thickness, and between 3 months vs. 23 months and 12 months vs. 23 months for podocyte width. Kidney International 2005 68, 2608-2620DOI: (10.1111/j.1523-1755.2005.00733.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Immunofluorescence staining of renal cortex for type IV collagen in 3-month-old (A), 6-month-old (B), 12-month-old (C), 19-month-old (D), and 23-month-old (E) mice. There was increased type IV collagen deposition with age. Kidney International 2005 68, 2608-2620DOI: (10.1111/j.1523-1755.2005.00733.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Immunofluorescence staining of renal cortex for fibronectin in 3-month-old (A), 6-month-old (B), 12-month-old (C), 19-month-old (D), and 23-month-old (E) mice. There was increased glomerular fibronectin deposition with age. Kidney International 2005 68, 2608-2620DOI: (10.1111/j.1523-1755.2005.00733.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Urinary protein excretion for the different ages of mice, expressed as urinary albumin to creatinine ratio. There was a significant age-related increase in urinary protein excretion. Kidney International 2005 68, 2608-2620DOI: (10.1111/j.1523-1755.2005.00733.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Oil Red O staining for 3-month-old (A), 6-month-old (B), 12-month-old (C), 19-month-old (D), and 23-month-old (E) mice. The staining revealed increased accumulation of lipids (arrows) starting at 12 months, and becoming much more prominent in the 23-month-old mice. Kidney International 2005 68, 2608-2620DOI: (10.1111/j.1523-1755.2005.00733.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 8 Renal triglyceride content of mice from different age groups. (A) Fasting mice. The mice showed a statistically significant increase in renal triglyceride content as a function of aging (P for trend <0.01). Comparisons of individual ages revealed significant differences between 3 months vs. 12, 19, and 23 months, 6 months vs. 19 and 23 months, and 12 months vs. 19 and 23 months. (B) Refed mice. The mice showed a statistically significant increase in renal triglyceride content as a function of aging (P for trend <0.01). Comparisons of individual ages revealed significant differences between 3 months vs. 19 and 23 months, 6 months vs. 19 and 23 months, and 12 months vs. 19 and 23 months. Kidney International 2005 68, 2608-2620DOI: (10.1111/j.1523-1755.2005.00733.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 9 Renal cholesterol content of mice from different age groups. (A) Fasting mice. The mice showed a statistically significant increase in renal cholesterol content as a function of aging (P for trend < 0.01). Comparisons of individual ages revealed significant differences between 3 months vs. 12, 19 and 23 months, and 6 months vs. 12, 19 and 23 months. (B) Refed mice. The mice showed a statistically significant increase in renal cholesterol content as a function of aging (P for trend < 0.01). Comparisons of individual ages revealed significant differences between 3 months vs. 12, 19, and 23 months, 6 months vs. 12, 19, and 23 months, and 12 months vs. 23 months. Kidney International 2005 68, 2608-2620DOI: (10.1111/j.1523-1755.2005.00733.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 10 Nuclear sterol regulatory element-binding proteins (SREBP-1) protein levels in kidney tissue for each age group. (A) Fasting mice. There was an age-related increase in the amount of renal nuclear SREBP-1 protein (P for trend < 0.01). Comparisons of individual ages revealed significant differences between 3 months vs. 12 and 23 months, and 12 months vs. 23 months. (B) Refed mice. There was an age-related increase in the amount of renal nuclear SREBP-1 protein (P for trend < 0.01). Comparisons of individual ages showed significant differences between 3 months vs. 12 and 23 months, and 12 months vs. 23 months. Kidney International 2005 68, 2608-2620DOI: (10.1111/j.1523-1755.2005.00733.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 11 Nuclear sterol regulatory element-binding proteins (SREBP-2) protein levels in kidney tissue for each age group. (A) Fasting mice. There was an age-related increase in the amount of renal nuclear SREBP-2 protein (P for trend < 0.01). Comparisons of individual ages showed significant differences between 3 months vs. 12 and 23 months, and 12 months vs. 23 months. (B) Refed mice. There was an age-related increase in the amount of renal nuclear SREBP-2 protein (P for trend < 0.01). Comparisons of individual ages showed significant differences between 3 months vs. 12 and 23 months, and 12 months vs. 23 months. Kidney International 2005 68, 2608-2620DOI: (10.1111/j.1523-1755.2005.00733.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 12 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase protein abundance for each 3, 12, and 23-month old mice. There was an age-related increase in HMG-CoA reductase protein levels (P for trend < 0.01). A comparison of individual ages showed significant differences between 3 months vs. 12 and 23 months. Kidney International 2005 68, 2608-2620DOI: (10.1111/j.1523-1755.2005.00733.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 13 Adenosine triphosphate (ATP) citrate lyase activity for each age group of mice. There was an increase in ATP citrate activity up to 19 months, and then a decrease was seen at 23 months. The increasing trend was significant (P = 0.0022). Comparisons of individual ages showed significant differences between 3 months vs. 12 and 19 months, and 6 months vs. 12 and 19 months. Kidney International 2005 68, 2608-2620DOI: (10.1111/j.1523-1755.2005.00733.x) Copyright © 2005 International Society of Nephrology Terms and Conditions